Amarin Corp Plc\uk paid its 5 named executives $9.5M in total in FY2025 (Dec). CEO Aaron D. Berg was paid $3.5M of that.
Pay$100 in the stock at the end of FY20 → $14
Pay of each named executive
Aaron D. BergPresident and Chief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Steven B. Ketchum, Ph.D.Executive Vice President, President of Research and Development and Chief Scientific Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
David P. Keenan, Ph. D.Executive Vice President, Chief Operating Officer
| FY2025 (Dec) |
1 year
Jonathan N. ProvoostExecutive Vice President, Chief Legal & Compliance Officer and Secretary
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) |
3 years
Peter L. FishmanSenior Vice President, Chief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) |
2 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 5 peers with pay on file was $5.4M. The CEO of Amarin Corp Plc\uk was paid $3.5M, 34% below the median.
- 1Travere Therapeutics
- 2Evolus
- 3Innoviva
- 4Rigel Pharmaceuticals
- 5Amarin Corp Plc\ukThis company
- 6Collegium Pharmaceutical
- 7Coherus BioSciences, Inc.Not disclosed
- 8Esperion Therapeutics, Inc.Not disclosed
- 9HarrowNot disclosed
- 10Heron Therapeutics, Inc.Not disclosed
- 11Ironwood Pharmaceuticals, Inc.Not disclosed
- 12Karyopharm Therapeutics, Inc.Not disclosed
- 13MacroGenics, Inc.Not disclosed
- 14Puma Biotechnology, Inc.Not disclosed
- 15Revance Therapeutics Inc.Not disclosed
- 16Vanda Pharmaceuticals Inc.Not disclosed
- 17Xeris Biopharma HoldingsNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.